Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children

Clin Infect Dis. 2020 Dec 15;71(12):3226-3228. doi: 10.1093/cid/ciaa584.

Abstract

The prevalence of antibodies to Strongyloides stercoralis was measured in 0-12-year-olds using a bead-based immunoassay before and after ivermectin mass drug administration (MDA) for scabies in the Solomon Islands. Seroprevalence was 9.3% before and 5.1% after MDA (P = .019), demonstrating collateral benefits of ivermectin MDA in this setting.

Keywords: Strongyloides; ivermectin; neglected tropical diseases; scabies.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Child
  • Humans
  • Ivermectin / therapeutic use
  • Melanesia / epidemiology
  • Prevalence
  • Scabies* / drug therapy
  • Scabies* / epidemiology
  • Seroepidemiologic Studies
  • Strongyloides stercoralis*
  • Strongyloidiasis* / drug therapy
  • Strongyloidiasis* / epidemiology

Substances

  • Ivermectin